Sign Up to like & get recommendations! 0
Published in 2024 at "NMR in Biomedicine"
DOI: 10.1002/nbm.5095
Abstract: The standard treatment in glioblastoma includes maximal safe resection followed by concomitant radiotherapy plus chemotherapy and adjuvant temozolomide. The first follow‐up study to evaluate treatment response is performed 1 month after concomitant treatment, when contrast‐enhancing regions… read more here.
Sign Up to like & get recommendations! 3
Published in 2022 at "Journal of Neurology"
DOI: 10.1007/s00415-022-11082-2
Abstract: In multiple sclerosis (MS), iron rim lesions (IRLs) are characterized by progressive tissue matrix damage. Therefore, early identification could represent an interesting target for therapeutic intervention to minimize evolving tissue damage. The aim of this… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Acta Neurochirurgica"
DOI: 10.1007/s00701-020-04318-5
Abstract: Background The purpose of this study was to assess the reliability of fluorescein sodium in predicting conclusive tissue diagnosis in stereotactic brain biopsies and to characterize features of contrast-enhancing and non-enhancing MRI lesions associated with… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noae165.0817
Abstract: Various intracranial tumors can lead to the development of perifocal edema. Differentiating edema from tumor on MRI might be easy in metastases and meningiomas but can be challenging in patients with glioblastoma. We set out… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Radiology"
DOI: 10.1148/radiol.2017160150
Abstract: Purpose To determine whether regions of low apparent diffusion coefficient (ADC) with high relative cerebral blood volume (rCBV) represented elevated choline (Cho)-to-N-acetylaspartate (NAA) ratio (hereafter, Cho/NAA ratio) and whether their volumes correlated with progression-free survival… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "PLoS ONE"
DOI: 10.1371/journal.pone.0183099
Abstract: Purpose In multiple sclerosis (MS) the sensitivity for detection of contrast enhancing lesions (CEL) in T1-weighted scans is essential for diagnostics and therapy decisions. The purpose of our study was to evaluate the sensitivity of… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "American Journal of Neuroradiology"
DOI: 10.3174/ajnr.a6025
Abstract: SUMMARY: There is a growing understanding of the prognostic importance of non-contrast-enhancing tumor in glioblastoma, and recent attempts at more aggressive management of this component using neurosurgical resection and radiosurgery have been shown to prolong… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Cancers"
DOI: 10.3390/cancers16071265
Abstract: Simple Summary Currently, contrast-enhancing gliomas FLAIRectomies or supramarginal gliresections are gaining momentum. This paper presents a semiquantitative analysis of FET uptake in biopsy targets inside and outside glioma masses based on PET/MR images. An exact… read more here.